Xebio Holdings Co., Ltd. carries a market capitalization of 42.00B, placing it among publicly traded companies globally. Its enterprise value stands at 42.44B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 42.00B |
| Enterprise Value | 42.44B |
Xebio Holdings Co., Ltd. currently has 43.08M shares outstanding.
| Shares Outstanding | 43.08M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Xebio Holdings Co., Ltd. trades at a trailing price-to-earnings ratio of 96.73. The price-to-sales ratio is 0.45, and the price-to-book ratio stands at 0.48.
| PE Ratio | 96.73 |
| PS Ratio | 0.45 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Xebio Holdings Co., Ltd. trades at an EV/EBITDA multiple of 34.34 and an EV/FCF ratio of 1,098.80. The EV/Sales ratio of 0.35 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.34 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.35 |
| EV / EBITDA | 34.34 |
| EV / EBIT | 34.34 |
| EV / FCF | 1,098.80 |
Xebio Holdings Co., Ltd. maintains a current ratio of 2.05, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.72, indicating elevated leverage, while an interest coverage ratio of 23.32 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.05 |
| Quick Ratio | 0.33 |
| Debt / Equity | 6.72 |
| Debt / EBITDA | 6.83 |
| Interest Coverage | 23.32 |
Xebio Holdings Co., Ltd. posts a return on equity of 0.50 and a return on invested capital of 0.66.
| Return on Equity (ROE) | 0.50 |
| Return on Assets (ROA) | 0.28 |
| Return on Invested Capital (ROIC) | 0.66 |
| Return on Capital Employed (ROCE) | 0.45 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.91 |
Over the trailing twelve months, Xebio Holdings Co., Ltd. has paid 233.00M in income taxes, reflecting an effective tax rate of 27.12.
| Income Tax | 233.00M |
| Effective Tax Rate | 27.12 |
Xebio Holdings Co., Ltd.'s stock has declined approximately -10.80844% over the past 52 weeks. The 50-day moving average sits at 1,011.08, while the 200-day moving average is 1,073.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.80844% |
| 50-Day Moving Average | 1,011.08 |
| 200-Day Moving Average | 1,073.25 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Xebio Holdings Co., Ltd. generated 122.38B in revenue and converted that into 571.00M in net income, yielding earnings per share of 14.13. EBITDA reached 1.24B, while operating income came in at 1.24B.
| Revenue | 122.38B |
| Gross Profit | 47.23B |
| Operating Income | 1.24B |
| Pretax Income | 859.00M |
| Net Income | 571.00M |
| EBITDA | 1.24B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | 14.13 |
Xebio Holdings Co., Ltd. holds 21.63B in cash and equivalents against 8.44B in total debt, resulting in a net debt position of -17.27B. Total book value stands at 115.05B, with working capital of 67.94B providing operational flexibility.
| Cash & Cash Equivalents | 21.63B |
| Total Debt | 8.44B |
| Net Debt | -17.27B |
| Equity (Book Value) | 115.05B |
| Book Value Per Share | 2,612.14 |
| Working Capital | 67.94B |
Xebio Holdings Co., Ltd. operates with a gross margin of 38.60, reflecting its pricing power and cost economics. The operating margin of 1.01 and net profit margin of 0.47 provide insight into operational efficiency.
| Gross Margin | 38.60 |
| Operating Margin | 1.01 |
| Pretax Margin | 0.70 |
| Profit Margin | 0.47 |
| EBITDA Margin | 1.01 |
Xebio Holdings Co., Ltd.'s most recent stock split took place on March 28, 2006 with a 2:3 split ratio.
| Last Split Date | 3/28/2006 |
| Split Ratio | 2:3 |
Xebio Holdings Co., Ltd. posts an Altman Z-Score of 2.21, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.21 |